Agora Labs raises €4.3M to expand clinical data infrastructure for medical research

Italian deeptech company Agora Labs has raised €4.3 million in a funding
round led by venture capital firm P101 SGR, with participation from the
Mussetto family, owners of Infinite Five, a holding company focused on
marketing technology, data analysis and robotics.

Founded in Rome by Davide Zaccagnini (CEO), a vascular surgeon and
biomedical informatician, and Fabio Giulietto, an engineer, Agora Labs develops
technology that enables hospitals to make clinical data available for medical
and scientific research while protecting patient privacy.

Hospitals generate large amounts of clinical data that could support
medical research and the development of new diagnostic and therapeutic
solutions. However, much of this information remains difficult to access and
analyse because it is fragmented across different IT systems and often stored
in unstructured formats.

Agora Labs aims to address this challenge through an infrastructure that
allows hospitals to process and standardise clinical data without transferring
it outside their own systems. The company installs dedicated computing nodes at
participating healthcare facilities, using GPUs supplied by technology partner
NVIDIA. Specialised large language models (LLMs) structure and standardise the
data, while anonymisation processes protect patient information.

Through federated AI technology, the infrastructure connects
participating hospitals, allowing research centres and pharmaceutical companies
to conduct studies using data from multiple healthcare facilities without
directly accessing patient records. AI models can also be trained and validated
locally, with only their outputs and inferences shared across the network.

This approach is designed to help healthcare institutions retain control
of their data while enabling researchers to analyse information from larger
patient populations across different countries. Agora Labs currently operates
through an international network of 50 healthcare facilities and plans to
double its size over the coming months.

Davide Zaccagnini, founder and CEO of Agora Labs, said the investment
would help the company accelerate the expansion of its healthcare network and
support larger international research projects.

The arrival of P101 and Infinite Five in Agora Labs addresses two
specific needs: scaling our data network even faster and activating
global-scale projects on it. Resources matter, but what counts most is
experience, market understanding, international credibility and genuine
strategic collaboration within the board.

Agora Labs operates in the Real World Evidence (RWE) market, which uses
clinical data collected during routine medical care to support research and the
development of healthcare solutions.

The new funding will help Agora Labs strengthen its presence in Europe
and the US while entering additional international markets, including the
Middle East and India. The company also plans to recruit around 20 technical
and commercial professionals in the coming months to support its expansion.